
Hemostasis and COVID-19
Managing coagulation abnormalities in COVID-19 patients
Don’t miss these events!
Join our highlights and scientific sessions.
Klok FA, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020.
Llitjos et al_High incidence of venous thromboembolic events in anticoagulated severe COVID-19. J Thromb Haemost. 2020.
Tang N, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020.
INNOVANCE and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. Sysmex is a trademark of the Sysmex Corporation. All other brands and trademarks are the property of their respective owners.
Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.